Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    weill | Open Studies | "Hepatitis C, Chronic"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Study of Oral Treatments for Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: sofosbuvir/ledipasvir;   Drug: ombitasvir/paritaprevir/ritonavir;   Drug: elbasvir/grazoprevir;   Drug: Dasabuvir
2 Recruiting Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT);   Drug: Dasabuvir (DSV);   Drug: Ribavirin (RBV)

Indicates status has not been verified in more than two years